1 |
Chuang YT, Tang JY, Shiau JP, Yen CY, Chang FR, Yang KH, Hou MF, Farooqi AA, Chang HW. Modulating Effects of Cancer-Derived Exosomal miRNAs and Exosomal Processing by Natural Products. Cancers (Basel) 2023;15. [PMID: 36612314 DOI: 10.3390/cancers15010318] [Reference Citation Analysis]
|
2 |
Lin L, Dai Y, Xia Y. An overview of aryl hydrocarbon receptor ligands in the Last two decades (2002–2022): A medicinal chemistry perspective. European Journal of Medicinal Chemistry 2022;244:114845. [DOI: 10.1016/j.ejmech.2022.114845] [Reference Citation Analysis]
|
3 |
Li H, Fu G, Zhong W. Natural quinazolinones: From a treasure house to promising anticancer leads. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114915] [Reference Citation Analysis]
|
4 |
Wu G, Hao Q, Liu B, Zhou J, Fan C, Liu R. Network pharmacology-based screening of the active ingredients and mechanisms of evodiae fructus anti-glioblastoma multiforme. Medicine (Baltimore) 2022;101:e30853. [PMID: 36181021 DOI: 10.1097/MD.0000000000030853] [Reference Citation Analysis]
|
5 |
Imran SJ, Vagaska B, Kriska J, Anderova M, Bortolozzi M, Gerosa G, Ferretti P, Vrzal R. Aryl Hydrocarbon Receptor (AhR)-Mediated Signaling in iPSC-Derived Human Motor Neurons. Pharmaceuticals 2022;15:828. [DOI: 10.3390/ph15070828] [Reference Citation Analysis]
|